Hims & Hers Health (HIMS) EBIT (2019 - 2026)

Hims & Hers Health has disclosed EBIT across 8 years of filings, most recently posting -$78.3 million for Q1 2026.

• EBIT for Q1 2026 came in at -$78.3 million, down 235.28% year-over-year; the trailing twelve-month figure through Mar 2026 was -$30.6 million (down 127.85% YoY), and the FY2025 annual result was $105.6 million, up 70.61% from the prior year.
• EBIT came in at -$78.3 million for Q1 2026 at Hims & Hers Health, down from $9.2 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $57.9 million in Q1 2025 to a low of -$78.3 million in Q1 2026.
• The 5-year median for EBIT is -$400000.0 (2023), against an average of -$526882.4.
• Across the five-year window, EBIT jumped 4749.0% in 2024 and tumbled 235.28% in 2026, its largest moves.
• Hims & Hers Health's EBIT stood at -$11.6 million in 2022, then soared by 96.55% to -$400000.0 in 2023, then surged by 4749.0% to $18.6 million in 2024, then plunged by 50.6% to $9.2 million in 2025, then slumped by 952.63% to -$78.3 million in 2026.
• The last three EBIT figures came in at -$78.3 million (Q1 2026), $9.2 million (Q4 2025), and $11.8 million (Q3 2025), per Business Quant data.